Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Jun-27-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| Rx Pharmaceuticals | | | | | 920.8 | 1,054.4 | | 936.0 |
| Other | | | | | | 55.7 | | 107.7 |
| |
| EBITDA |
| Rx Pharmaceuticals | | | | | 314.2 | 410.0 | 119.9 | 430.4 |
| Specialty Sciences | | | | | | | | -16.1 |
| Other | | | | | | 14.5 | -187.3 | 37.4 |
| |
| EBIT |
| Rx Pharmaceuticals | | | | | 214.6 | 306.1 | -0.2 | 364.7 |
| Specialty Sciences | | | | | | | | -17.6 |
| Other | | | | | | 8.7 | -195.1 | 26.8 |
| |
| Mix |
| Rx Pharmaceuticals | | | | | 19.5% | 21.3% | | 22.1% |
| Other | | | | | | 1.1% | | 2.5% |
| |
| Growth |
| Rx Pharmaceuticals | | | | | -12.7% | | | 1.0% |
| Other | | | | | | | | -21.7% |
|